Strides gains USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg EP News Bureau Sep 6, 2024 Strides is eligible for 180 days of Competitive Generic Therapy (CGT) exclusivity for Theophylline Extended-Release Tablets, 300…
Glenmark gets US FDA approval for Theophylline ER Tablets, 300 mg and 450 mg EP News Bureau Jun 4, 2021 Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg
